The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Mundipharma; Novartis; Roche/Genentech
Phase 1/2 study of weekly nab-paclitaxel (nab-P) in pediatric patients (pts) with recurrent/refractory solid tumors (STs): dose-finding and pharmacokinetics (PK).
 
Lucas Moreno
No Relationships to Disclose
 
Michela Casanova
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Loxo; Roche
 
Julia C. Chisholm
Consulting or Advisory Role - La Roche-Posay; Merck Sharp & Dohme; Roche
 
Pablo Berlanga
No Relationships to Disclose
 
Pascal B. Chastagner
No Relationships to Disclose
 
Sylvain Baruchel
Stock and Other Ownership Interests - Metronomic
Honoraria - Celgene
Consulting or Advisory Role - Celgene
Research Funding - SERVIER
 
Carla Manzitti
No Relationships to Disclose
 
Soledad Gallego Mélcon
No Relationships to Disclose
 
Nicolas U. Gerber
No Relationships to Disclose
 
Gianni Bisogno
Consulting or Advisory Role - Loxo
Research Funding - Indena (Inst)
 
Franca Fagioli
No Relationships to Disclose
 
Birgit Geoerger
No Relationships to Disclose
 
Julia Glade Bender
Research Funding - Celgene (Inst); Merck (Inst)
 
Isabelle Aerts
No Relationships to Disclose
 
Christophe Bergeron
No Relationships to Disclose
 
Pooja Hingorani
No Relationships to Disclose
 
Ileana Elias
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Mathew Simcock
No Relationships to Disclose
 
Ruta Slepetis
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Gilles Vassal
Research Funding - Celgene (Inst)